Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ichiro Yonese
Institutions:
Tokyo Metropolitan Komagome Hospital,
Saitama Red Cross Hospital
Observed institutions:
Tokyo Medical and Dental University,
Tokyo Metropolitan Komagome Hospital,
The Cancer Institute Hospital,
Saitama Red Cross Hospital,
Japanese Foundation For Cancer Research
ORCID:
0009-0001-2607-1013
Observed ORCID:
0009-0001-2607-1013
OpenAlex ID:
A5018324655
Nationwide survey of systemic chronic active EBV infection in Japan in accordance with the new WHO classification
2020
·
Ichiro Yonese
, Chizuko Sakashita
, et al.
·
Blood Advances
·
107
CD79B mutations in primary vitreoretinal lymphoma: Diagnostic and prognostic potential
2018
·
Ichiro Yonese
, Hiroshi Takase
, et al.
·
European Journal Of Haematology
·
80
Selection bias due to delayed comprehensive genomic profiling in Japan
2022
·
Taichi Tamura
, Masachika Ikegami
, et al.
·
Cancer Science
·
27
PDF
A Case of Metastatic Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome-Associated Renal Cell Carcinoma Treated with a Sequence of Axitinib and Nivolumab Following Cytoreductive Nephrectomy
2020
·
Ichiro Yonese
, Masaya Ito
, et al.
·
Journal of Kidney Cancer and VHL
·
19
PDF
Preoperative models incorporating the systemic immune-inflammation index for predicting prognosis and muscle invasion in patients with non-metastatic upper tract urothelial carcinoma
2021
·
Shuichiro Kobayashi
, Masaya Ito
, et al.
·
International Journal of Clinical Oncology
·
16
Impact of diagnostic ureteral catheterization on intravesical tumour recurrence following radical nephroureterectomy for upper tract urothelial carcinoma
2023
·
Ichiro Yonese
, Masaya Ito
, et al.
·
World Journal of Urology
·
11
Superior detection of significant prostate cancer by transperineal prostate biopsy using MRI-transrectal ultrasound fusion image guidance over cognitive registration
2023
·
Masaya Ito
, Ichiro Yonese
, et al.
·
International Journal of Clinical Oncology
·
9
PDF
Clinical significance of anti-Epstein–Barr virus antibodies in systemic chronic active Epstein–Barr virus disease
2024
·
Miwako Nishio
, Minori Saito
, et al.
·
Frontiers in Microbiology
·
8
PDF
Adverse Prognostic Impact of Diagnostic Ureterorenoscopy in a Subset of Patients with High-Risk Upper Tract Urothelial Carcinoma Treated with Radical Nephroureterectomy
2022
·
Ichiro Yonese
, Masaya Ito
, et al.
·
Cancers
·
5
PDF
Primary Testicular Neuroendocrine Tumor Coexisting With Seminoma Sharing Germ Cell Origin
2021
·
Noriyuki Iida
, Kosuke Takemura
, et al.
·
International Journal of Surgical Pathology
·
3
Prognostic Significance of Hypoalbuminemia in Maintenance Avelumab Therapy After First‐Line Chemotherapy for Metastatic Urothelial Carcinoma: A Multicenter Real‐World Study ( YUSHIMA Study)
2026
·
Rie Muta
, Hiroshi Fukushima
, et al.
·
International Journal of Urology
·
2
Real-world efficacy of enfortumab vedotin in Japanese patients with metastatic urothelial carcinoma stratified by EV-301 trial eligibility: a multicenter Bayesian restricted mean survival time analysis
2026
·
Shugo Yajima
, Soichiro Yoshida
, et al.
·
Japanese Journal of Clinical Oncology
·
2
Performance of Prognostic Models in Patients With Metastatic Urothelial Carcinoma Treated With Enfortumab Vedotin After Platinum‐Based Chemotherapy and Immune Checkpoint Inhibitors: YUSHIMA Study
2026
·
Hiroki Shimoda
, Yuki Nakamura
, et al.
·
International Journal of Urology
·
1
Real-world insights from comprehensive genomic profiling in patients with metastatic castration-resistant prostate cancer
2026
·
Yosuke Yasuda
, Soichiro Yoshida
, et al.
·
Japanese Journal of Clinical Oncology
·
1
Impact of IRAES on the outcomes of pembrolizumab therapy in patients with MUC: A comprehensive analysis of severity and the type and number of affected organs
2025
·
Ichiro Yonese
, Yosuke Yasuda
, et al.
·
Urologic Oncology Seminars and Original Investigations
·
1
Clinical outcomes of patients with metastatic fumarate hydratase‐deficient renal cell carcinoma: A single‐center case series
2025
·
Ichiro Yonese
, Kosuke Takemura
, et al.
·
International Journal of Urology
·
1
PDF
A Nationwide Survey on Chronic Active Epstein-Barr Virus Infection in Japan Based on New Diagnostic Criteria: Clinical Features and Treatment Strategies
2018
·
Ayako Arai
, Ichiro Yonese
, et al.
·
Blood
·
1
C-reactive protein at pembrolizumab initiation and its trajectory from first-line chemotherapy as prognostic markers in metastatic urothelial carcinoma (YUSHIMA study)
2026
·
Shugo Yajima
, Soichiro Yoshida
, et al.
·
International Urology and Nephrology
Real‐World Outcomes of Olaparib Treatment in Japanese Patients With Metastatic Castration‐Resistant Prostate Cancer Harboring BRCA Pathogenic or Likely Pathogenic Variants
2026
·
Yosuke Yasuda
, Soichiro Yoshida
, et al.
·
International Journal of Urology
Ip73-03 Real-world Outcomes of Triplet Intensification in High-volume Metastatic Hormone-sensitive Prostate Cancer in Japanese Patients From the Prospective Yushima Registry: Propensity-weighted and Bayesian Rmst Analysis
2026
·
Yoshitomo Yamaguchi
, Yosuke Yasuda
, et al.
·
The Journal of Urology
PDF
Adverse impact of bladder biopsy on the rate of intravesical recurrences following radical nephroureterectomy for upper tract urothelial carcinoma
2026
·
Tomonori Kanagawa
, Ichiro Yonese
, et al.
·
Japanese Journal of Clinical Oncology
Real‐World Comparison of Triplet Versus Doublet Therapy in Japanese Patients With High‐Volume Metastatic Hormone‐Sensitive Prostate Cancer: A Propensity‐Weighted Analysis From the YUSHIMA Registry and Exploratory Bayesian Evidence Synthesis
2026
·
Yosuke Yasuda
, Soichiro Yoshida
, et al.
·
The Prostate
Lymph node metastasis as a favorable prognostic factor in metastatic urothelial carcinoma with histological variants treated with pembrolizumab: a retrospective multicentric study (YUSHIMA study-04)
2026
·
Ichiro Yonese
, Fumitaka Koga
, et al.
·
Japanese Journal of Clinical Oncology
PDF
Ip21-17 How Many Systematic Biopsy Cores Can Be Safely Reduced in Transperineal Mri/trus Fusion Image-guided Targeted Biopsy?
2025
·
Masaya Ito
, Ichiro Yonese
, et al.
·
The Journal of Urology
PDF
A case of neoadjuvant chemotherapy‐resistant muscle‐invasive bladder cancer that markedly responded to pembrolizumab before conversion radical cystectomy
2023
·
Ichiro Yonese
, Noboru Numao
, et al.
·
IJU Case Reports
Show more works
View as search
Works count:
25
Citation count:
294
H-index:
8
I10-index:
6
Year
Topic
Type